Behind the Scenes, McKinsey Guided Companies at the Center of the Opioid Crisis
The consulting firm offered clients “in-depth experience in narcotics,” from poppy fields to pills more powerful than Purdue’s OxyContin.
The consulting firm offered clients “in-depth experience in narcotics,” from poppy fields to pills more powerful than Purdue’s OxyContin.
Three critical questions to secure F.D.A. integrity.
The consulting firm’s top executive was apologetic before Congress but denied that advising both opioid manufacturers and their federal regulator posed a conflict of interest.
The consulting firm’s top executive was apologetic before Congress but denied that advising both opioid manufacturers and their federal regulator posed a conflict of interest.
The consulting firm’s top executive was apologetic before Congress but denied that advising both opioid manufacturers and their federal regulator posed a conflict of interest.
The consulting firm’s top executive was apologetic before Congress but denied that advising both opioid manufacturers and their federal regulator posed a conflict of interest.
House Democrats on Wednesday questioned the consulting firm McKinsey & Company over its simultaneous work with both the Food and Drug Administration (FDA) and Purdue […]
Three critical questions to secure F.D.A. integrity.
The firm let consultants advise both drugmakers and their government overseers, internal records show. “Who we know and what we know” was part of their […]
Purdue Pharma and its controlling Sackler family have reach a new settlement to resolve lawsuits over their involvement in the opioid epidemic, raising the payout […]
Money from the tentative deal would go toward addiction and treatment and would be overseen by Native American tribal leaders.
The ruling said the company’s owners, members of the Sackler family, could not receive protection from civil lawsuits in return for a $4.5 billion contribution.
The ruling said the company’s owners, members of the Sackler family, could not receive protection from civil lawsuits in return for a $4.5 billion contribution.
A judge in the US has rejected the bankruptcy plan proposed by Purdue Pharma to settle legal action over its role in the opioid crisis, […]
The ruling said the company’s owners, members of the Sackler family, could not receive protection from civil lawsuits in return for a $4.5 billion contribution.
The ruling said the company’s owners, members of the Sackler family, could not receive protection from civil lawsuits in return for a $4.5 billion contribution.
The agency that regulates drug safety has become too cozy with the industry it’s supposed to oversee.
The agency that regulates drug safety has become too cozy with the industry it’s supposed to oversee.
The agency that regulates drug safety has become too cozy with the industry it’s supposed to oversee.
A US federal judge has approved a bankruptcy settlement for Purdue Pharma that grants the Sackler family that owned the business immunity from any further […]
The ruling in bankruptcy court caps a long legal battle over the fate of a company accused of fueling the opioid epidemic and the family […]
The ruling in bankruptcy court caps a long legal battle over the fate of a company accused of fueling the opioid epidemic and the family […]
In a rare courtroom appearance, the former Purdue Pharma president and board member was evasive and defiant.
In a rare courtroom appearance, the former Purdue Pharma president and board member was evasive and defiant.
In a rare court appearance, David Sackler said he and his family would withdraw their pledge to pay $4.5 billion, unless they are shielded from […]
In a rare court appearance, David Sackler said he and his family would withdraw their pledge to pay $4.5 billion, unless they are granted broad […]
If approved by a judge next month, the plan would resolve thousands of lawsuits and set in motion the release of $4.5 billion to help […]
If approved by a judge next month, the plan would resolve thousands of lawsuits and set in motion the release of $4.5 billion to help […]
The payout to New York will take place over the next 17 years, and joins a $26 billion deal to settle the thousands of nationwide […]
Three drug distributors and Johnson & Johnson are also on the verge of a $26 billion deal to settle the thousands of nationwide lawsuits.
The agreement would end thousands of lawsuits against the three largest distributors and Johnson & Johnson and require them to pay billions for addiction treatment […]
The states, including Massachusetts and New York, agreed to drop opposition to the bankruptcy organization plan of the company, the maker of OxyContin.
The states, including Massachusetts and New York, agreed to drop opposition to the bankruptcy organization plan of the company, the maker of OxyContin.
New York’s sweeping lawsuit is the first opioid case in which a jury rather than a judge will decide the outcome.
New York’s sweeping lawsuit is the first opioid case in which a jury rather than a judge will decide the outcome.
New York’s sweeping lawsuit is the first opioid case in which a jury rather than a judge will decide the outcome.
The consulting firm has reached the agreement with 47 states because of its advice to drugmakers, including Purdue Pharma, the manufacturer of OxyContin.
The firm faced criticism after a report revealed that consultants had discussed destroying documents related to the opioid business and proposed that a drugmaker pay […]
The firm faced criticism after a report revealed that consultants had discussed destroying documents related to the opioid business and proposed that a drugmaker pay […]
Court filings reveal consultants’ talk of a records purge during the opioid crisis, and shed new light on sales advice given to the billionaire Sackler […]
After years of legal wrangling, Purdue Pharma has agreed a deal to resolve litigation about its role in the US opioid epidemic that will cost […]
In addition to monetary damages and the guilty pleas, the government is seeking to transform the maker of OxyContin into a public benefit company that […]
Nearly all of the states, plus five territories and the District of Columbia, are seeking an aggregate of $2.156 trillion from the maker of the […]
Copyright © 2024 | WordPress Theme by MH Themes